Thrivent Financial for Lutherans
SGNT

Thrivent Financial for Lutherans’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Thrivent Financial for Lutherans’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11,660
Closed -$175K – 2075
2016
Q2 		$175K Buy
11,660
+720
+7% +$9.25K ﹤0.01% 1828
2016
Q1 		$133K Sell
10,940
-35,270
-76% -$495K ﹤0.01% 1818
2015
Q4 		$735K Buy
46,210
+12,110
+36% +$191K ﹤0.01% 1179
2015
Q3 		$523K Buy
34,100
+25,150
+281% +$544K ﹤0.01% 1192
2015
Q2 		$218K Sell
8,950
-41,700
-82% -$999K ﹤0.01% 1585
2015
Q1 		$1.18M Hold
50,650
– – 0.01% 792
2014
Q4 		$1.27M Buy
50,650
+42,500
+521% +$1.25M 0.01% 794
2014
Q3 		$253K Buy
+8,150
New +$221K ﹤0.01% 1469

Thrivent Financial for Lutherans's SGNT Position: Q3 2016 in Review

Thrivent Financial for Lutherans sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 11,660 shares — an estimated $175K sold.

Thrivent Financial for Lutherans first reported a position in SGNT in Q3 2014 and held it in 8 quarters. The position peaked at $1.27M in Q4 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Thrivent Financial for Lutherans reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 11,660 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $175K.
  • Thrivent Financial for Lutherans first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 8 quarters.
  • Thrivent Financial for Lutherans's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.27M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2016, filed 14 Nov 2016.